Proshares Trust (ZBIO) Cash & Current Investments (2023 - 2025)
Historic Cash & Current Investments for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $476.9 million.
- Zenas BioPharma's Cash & Current Investments rose 3243.08% to $476.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $476.9 million, marking a year-over-year increase of 3243.08%. This contributed to the annual value of $350.8 million for FY2024, which is 51692.67% up from last year.
- According to the latest figures from Q3 2025, Zenas BioPharma's Cash & Current Investments is $476.9 million, which was up 3243.08% from $504.2 million recorded in Q2 2025.
- Zenas BioPharma's Cash & Current Investments' 5-year high stood at $504.2 million during Q2 2025, with a 5-year trough of $37.2 million in Q1 2024.
- Its 3-year average for Cash & Current Investments is $274.7 million, with a median of $350.8 million in 2024.
- The largest annual percentage gain for Zenas BioPharma's Cash & Current Investments in the last 5 years was 105473.95% (2025), contrasted with its biggest fall of 3243.08% (2025).
- Zenas BioPharma's Cash & Current Investments (Quarter) stood at $56.9 million in 2023, then skyrocketed by 516.93% to $350.8 million in 2024, then surged by 35.97% to $476.9 million in 2025.
- Its Cash & Current Investments was $476.9 million in Q3 2025, compared to $504.2 million in Q2 2025 and $430.0 million in Q1 2025.